Gordon Carl L (CIK 0001282930)

Latest company ownership

PHGE - BiomX Inc.
Role: 10% Owner
Shares held
9,280,408
Last filed at
May 20, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q1 2025Q4
Shares held
3,571,428
Last filed at
Nov 8, 2021
Confidence Score
48.4
2025Q4
Confidence Score History
2020Q2 2025Q4
Shares held
2,212,571
Last filed at
Mar 31, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
Shares held
1,847,400
Last filed at
May 11, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4
Shares held
755,635
Last filed at
Jul 17, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
747,887
Last filed at
Feb 19, 2025
Confidence Score
50.5
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
708,201
Last filed at
Jun 29, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4
Shares held
469,615
Last filed at
Jan 31, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q1 2025Q4
Shares held
119,522
Last filed at
Aug 15, 2024
Confidence Score
25.6
2025Q4
Confidence Score History
2020Q2 2025Q4
ACET - Adicet Bio, Inc.
Role: Director
Shares held
26,400
Last filed at
Aug 23, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q2 2025Q4
ALEC - Alector, Inc.
Role: Director
Shares held
20,000
Last filed at
May 14, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q1 2025Q4
Shares held
10,000
Last filed at
Jun 7, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4
AMRN - AMARIN CORP PLC\UK
Role: Director
Shares held
5,700
Last filed at
Sep 5, 2012
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 21, 2025 Dec 18, 2025 Keros Therapeutics, Inc. Director Sell 17.5 -214,522 -21.06% ✗ $3.8M
Apr 9, 2025 Apr 11, 2025 Compass Therapeutics, Inc. Director Sell 16.3 -3,571,428 -100.00% ✗ $5.7M
Feb 14, 2025 Feb 19, 2025 MBX Biosciences, Inc. Director Buy 87.5 +190,672 1.87% ✗ $2M
Sep 16, 2024 Sep 17, 2024 MBX Biosciences, Inc. Director Buy 100.0 +750,000 24.49% ✗ $12M
Aug 13, 2024 Aug 15, 2024 Keros Therapeutics, Inc. Director Sell 15.0 -250,000 -19.70% ✗ $11M
Jul 15, 2024 Jul 17, 2024 Terns Pharmaceuticals, Inc. Director Sell 37.5 -56,164 -0.37% ✗ $561.6K
May 15, 2024 May 20, 2024 BiomX Inc. 10% Owner Sell 52.5 -24,344 -0.18% ✗ $9.3K
Jan 30, 2024 Jan 31, 2024 ArriVent BioPharma, Inc. Director Buy 100.0 +444,444 17.21% ✗ $8M
Jan 25, 2024 Jan 26, 2024 Adicet Bio, Inc. Director Buy 100.0 +3,125,000 47.01% ✗ $7.5M
Jun 27, 2023 Jun 29, 2023 Adicet Bio, Inc. Director Buy 100.0 +875,000 12.10% ✗ $1.8M
Feb 27, 2023 Mar 17, 2023 BiomX Inc. 10% Owner Buy 95.0 +348,000 12.37% ✗ $85.3K
Dec 23, 2022 Dec 28, 2022 Terns Pharmaceuticals, Inc. Director Buy 90.0 +137,931 2.91% ✗ $1000K
Nov 8, 2022 Nov 10, 2022 Compass Therapeutics, Inc. Director Buy 92.5 +402,000 2.71% ✗ $1.3M
Aug 16, 2022 Aug 18, 2022 Terns Pharmaceuticals, Inc. Director Buy 100.0 +3,690,000 97.33% ✗ $8.9M
May 11, 2022 May 13, 2022 Compass Therapeutics, Inc. Director Buy 85.0 +192,516 1.32% ✗ $420.5K
May 6, 2022 May 10, 2022 Compass Therapeutics, Inc. Director Buy 72.5 +125,359 0.86% ✗ $197.3K
Nov 4, 2021 Nov 8, 2021 Compass Therapeutics, Inc. Director Buy 100.0 +5,357,143 42.13% ✗ $18.8M
Mar 29, 2021 Mar 31, 2021 Oric Pharmaceuticals, Inc. Director Sell 32.5 -103,424 -4.47% ✓ $2.4M
Mar 24, 2021 Mar 26, 2021 Oric Pharmaceuticals, Inc. Director Sell 32.5 -112,298 -4.62% ✓ $2.8M
Mar 19, 2021 Mar 23, 2021 Oric Pharmaceuticals, Inc. Director Sell 42.5 -32,940 -1.34% ✓ $863.3K
Mar 16, 2021 Mar 18, 2021 Oric Pharmaceuticals, Inc. Director Sell 36.3 -66,202 -2.62% ✓ $1.9M
Mar 11, 2021 Mar 15, 2021 Oric Pharmaceuticals, Inc. Director Sell 22.5 -238,282 -8.62% ✓ $7.3M
Feb 9, 2021 Feb 9, 2021 Terns Pharmaceuticals, Inc. Director Buy 100.0 +475,000 14.32% ✗ $8.1M
Jun 19, 2020 Jun 23, 2020 Compass Therapeutics, Inc. Director Buy 100.0 +1,455,132 12.92% ✗ $7.3M
Apr 24, 2020 Apr 28, 2020 Oric Pharmaceuticals, Inc. Director Buy 100.0 +281,250 100.00% ✗ $4.5M
Apr 13, 2020 Apr 13, 2020 Keros Therapeutics, Inc. Director Buy 100.0 +375,200 50.39% ✗ $6M
Feb 11, 2019 Feb 11, 2019 Alector, Inc. Director Buy 93.8 +411,700 3.25% ✗ $7.8M
Nov 20, 2017 Nov 20, 2017 X4 Pharmaceuticals, Inc Director Buy 100.0 +500,000 36.52% ✗ $5M
Jun 27, 2016 Jun 29, 2016 Cartesian Therapeutics, Inc. Director Buy 100.0 +550,000 42.54% ✗ $7.7M
May 11, 2016 May 11, 2016 Intellia Therapeutics, Inc. Director Buy 100.0 +250,000 10.36% ✗ $4.5M
Sep 4, 2012 Sep 5, 2012 AMARIN CORP PLC\UK Director Sell 5.0 -233,700 -28.03% ✓ $3.4M
Jul 27, 2012 Jul 30, 2012 AMARIN CORP PLC\UK Director Sell 3.8 -366,300 -30.53% ✓ $5.4M
Jun 19, 2012 Jun 19, 2012 AMARIN CORP PLC\UK Director Sell 16.3 -617,100 -33.96% ✗ $8M